8-Bromo-3-Methylxanthine CAS 93703-24-3 Linagliptin Intermediate Purity ≥99.0% Factory

Inkcazelo emfutshane:

Igama leKhemikhali: 8-Bromo-3-Methylxanthine

CAS: 93703-24-3

Ubunyulu: ≥99.0%

Imbonakalo: Umgubo oMhlophe ukuya kokuKhanyayo oMthubi

I-Intermediate ye-Linagliptin (CAS: 668270-12-0) yonyango lwe-II diabetes mellitus

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo loMvelisi iLinagliptin kunye neMidiya eNxulumeneyo:
I-Linagliptin CAS 668270-12-0
ILinagliptin yoMzali iNyucleus ePhakathi CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
I-8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
I-2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0

Iipropati zeMichiza:

Igama leMchiza	8-Bromo-3-Methylxanthine
Izithethantonye	I-8-Bromo-3-Methyl-3,7-dihydro-1H-purine-2,6-dione
Inombolo yeCAS	93703-24-3
Inombolo yeCAT	RF-PI501
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C6H5BrN4O2
Ubunzima beMolekyuli	245.03
Indawo yokunyibilika	300℃(lit.)
Ukuxinana	1.974g/cm3
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe ukuya koMthubi oKhanyayo
Ubunyulu	≥99.0%
Ilahleko ekomisweni	≤0.50%
Intsalela kwi-Ignition	≤0.50%
Ukungacoceki Okukodwa	≤0.50%
Ukungcola ngokupheleleyo	≤1.0%
Iintsimbi ezinzima	≤20ppm
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Esiphakathi kwiLinagliptin (CAS: 668270-12-0)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-8-Bromo-3-Methylxanthine (i-CAS: 93703-24-3) ithathwe endaweni ye-Xanthine.Ingasetyenziselwa ukuhlanganiswa kweLinagliptin (i-CAS: 668270-12-0), eyona nto inoveli enamandla kunye ne-dipeptidyl peptidase-4 (DPP-4) inhibitor ekhethiweyo kunye nokusetyenziswa okunokwenzeka kunyango lwe-2 yeswekile.Yavunywa yi-US FDA ngoMeyi 2011 kunyango lwe-Type 2 yeswekile kunye nokutya kunye nokuzilolonga.Umsunguli nguBoehringer Ingelheim (eUnited States).